NASDAQ:PETS PetMed Express Q2 2027 Earnings Report $1.28 +0.01 (+0.39%) As of 12:34 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast PetMed Express EPS ResultsActual EPSN/AConsensus EPS -$0.11Beat/MissN/AOne Year Ago EPSN/APetMed Express Revenue ResultsActual RevenueN/AExpected Revenue$62.00 millionBeat/MissN/AYoY Revenue GrowthN/APetMed Express Announcement DetailsQuarterQ2 2027Date10/13/2026TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile PetMed Express Earnings HeadlinesPetMed Express (PETS) Projected to Release Quarterly Earnings on TuesdayOctober 6 at 1:26 AM | americanbankingnews.comContrasting PetMed Express (NASDAQ:PETS) & Lands' End (NASDAQ:LE)October 3, 2026 | americanbankingnews.comA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering real expenses, that rhythm rarely lines up with the bills. Nathan Slaughter, Chief Investment Strategist at High-Yield Investing, built a full 52-week calendar by sequencing quality dividend payers so every week is covered, including bonus dividends that cluster from December through February.October 8 at 1:00 AM | Market Savvy (Ad)PetMed Express consensus price target cut by 34.88% to $1.43October 2, 2026 | msn.comPetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | globenewswire.comPetMed Express Amends Plan for New CEO Equity AwardsSeptember 28, 2026 | tipranks.comSee More PetMed Express Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email. Email Address About PetMed ExpressPetMed Express (NASDAQ:PETS) is an online pet pharmacy and specialty retailer that markets pet medications, food, and healthcare products directly to consumers. The company operates under the 1-800-PetMeds brand and focuses primarily on products for dogs and cats. Its product offerings include prescription and nonprescription medications, flea and tick treatments, heartworm preventives, supplements, and other veterinary health products. PetMed Express also sells pet food, treats, supplies, and select general wellness products through its digital platforms and customer service channels. Founded in 1996, the company serves pet owners throughout the United States. Customers can order eligible prescription medications through the company’s online pharmacy, subject to verification and authorization from their veterinarians. PetMed Express is headquartered in Florida and has been publicly traded on the Nasdaq under the symbol PETS.View PetMed Express ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Skydance Just Became a Media Giant—With an $80 Billion Debt LoadConstellation Brands Beat Earnings, But Beer Demand Is Still a ProblemTesla's EV Delivery Beat Is In, So What Happens Now?BigBear.ai Is Heavily Shorted—and Its Fundamentals Are Starting to ChangePenguin Solutions Is Soaring as AI Memory Demand ExplodesDoes Lemonade’s Growth Signal Profits Ahead?Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run Upcoming Earnings Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
